
Tirzepatide NEW
Price | $1 |
Package | 1KG |
Min. Order: | 10KG |
Supply Ability: | 1000 |
Update Time: | 2025-04-27 |
Product Details
Product Name: Tirzepatide | CAS No.: 2023788-19-2 |
Min. Order: 10KG | Purity: 99% |
Supply Ability: 1000 | Release date: 2025/04/27 |
Optimize Diabetes Management with Tirzepatide CAS:2023788-19-2 – Dual GIP and GLP-1 Benefits
Category Details
Chemical Name:Tirzepatide
CAS:2023788-19-2
Molecular Formula C???H???N??O??S?
Molecular Weight Approximately 4813.5 g/mol
Chemical Structure A dual receptor agonist consisting of a 39-amino acid peptide chain with GIP and GLP-1 receptor agonist activity.
Mechanism of Action:Activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, regulating blood sugar and body weight.
Indication:Treatment of type 2 diabetes
Administration:Subcutaneous injection
English Summary:Tirzepatide is a dual GIP and GLP-1 receptor agonist developed by Eli Lilly and Company for the treatment of type 2 diabetes. It improves glycemic control, promotes weight loss, and may offer cardiovascular benefits. Clinical trials have demonstrated its efficacy in reducing blood glucose levels and body weight. It is administered via subcutaneous injection.
Tests | Specifications | Results |
Appearance | White powder | Conforms |
Solubility | Freely soluble in water | Conforms |
pH | 6.0-9.0 | 7.5 |
Amino acid analysis | Conform | Conform |
Acetic acid | <0.5% | 0.0% |
TFA | <0.5% | 0.0% |
Water Content | ≤10.0% | 5.6% |
Sodium ion | ≤5.0% | 1.6% |
Purity(HPLC) | ≥ 99.0% | 99.5% |
ImpurityⅠ:NMT 0.3% | N.D | |
ImpurityⅡ:NMT 0.3% | 0.27% | |
ImpurityⅢ:NMT 0.3% | 0.09% | |
ImpurityIV:NMT 0.3% | N.D | |
Any individual impurity: NMT 0.3% | 0.08% | |
Total impurities:NMT1.5% | 0.45% | |
Mass spectrum | 4813.4±1.0 | Conform |
Bacterial endotoxins | <5EU/mg | Conform |
Peptide content | ≥85.0% | 94.1% |
High molecular protein | ≤0.5% | 0.05% |
Microbial Limits | Total oxygen demand≤1000cfu/g | Less than20cfu/g |
Total aerobic microbial count ≤1000cfu/g | Less than 20cfu/g | |
Number of mold and yeast≤200cfu/g | Less than20cfu/g | |
Total yeast and mold count ≤100cfu/g | Less than 20cfu/g | |
Do not detect Escherichia coli | not detected | |
Escherichia coli:Absent | Absent | |
residual solvents | Acetonitrile≤410ppm | 70ppm |
Methanol≤3000ppm | N.D | |
Piperidine≤5000ppm | N.D | |
DMF≤880ppm | N.D | |
Triethylamine ≤320ppm | N.D | |
DCM≤600ppm | N.D | |
Assay(HPLC) | 95.0%-105.0% | 99.6% |
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$0.00/1box |
VIP1Y
|
Xi an Biohorlden Industry Trade Co Ltd
|
2025-04-24 | |
$0.00/1Box |
VIP1Y
|
Wuhan Kejiefeng Trading Co.,Ltd
|
2025-04-14 | |
$1.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-04-10 | |
$10.00/1box |
VIP3Y
|
TAIWAN OYI PEPTIDE CO., LTD
|
2025-03-31 | |
$0.00/1G |
VIP5Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2025-03-31 | |
$0.00/5mg |
VIP1Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2025-03-28 | |
$100.00/1gram |
VIP1Y
|
Hybio Pharmaceutical Co., Ltd.
|
2025-03-25 | |
$50.00/1kit |
VIP1Y
|
Shenzhen Aoxi Technology Co., Ltd.
|
2025-03-24 | |
$40.00/1box |
VIP1Y
|
Shenzhen Wolid Technology Co., Ltd.
|
2025-03-17 | |
$35.71/1Box |
VIP1Y
|
American HealthyMorph LLC
|
2025-03-10 |
- Since: 2019-11-21
- Address: Room E020, 4th Floor (1-3), Building 5, International Enterprise Center, No.1 Guanshan Second Road,
+86-18565342920
sales@chembj.net